SCHEMBL4035478

SCHEMBL4035478

CCOC(=O)[C@H](N)Cc1ccc(Br)c(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPH1 P17752 2/20 0.42
PDCD1 Q15116 1/20 0.41
CD274 Q9NZQ7 1/20 0.41
ALDH1A1 P00352 1/20 0.40
SLC7A5 Q01650 3/20 0.40
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
EGFR P00533 1/20 0.40
LCK P06239 1/20 0.40
FYN P06241 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ALOX15 P16050 1/20 0.40
PTGS1 P23219 1/20 0.40
HTR2A P28223 1/20 0.40
PTGS2 P35354 1/20 0.40
RECQL P46063 1/20 0.40
HIF1A Q16665 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MMP8 P22894 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3877275 1.00 TPH1 (0.42) TPH1PDCD1CD274ALDH1A1SLC7A5
SCHEMBL4035263 1.00 TPH1 (0.42) TPH1PDCD1CD274ALDH1A1SLC7A5
SCHEMBL4717339 0.90 ALDH1A1 (0.42) TPH1PDCD1CD274ALDH1A1SLC7A5
Hydrochloric Acid SCHEMBL3316938 0.88 TPH1 (0.42) TPH1PDCD1CD274ALDH1A1SLC7A5
SCHEMBL3751437 0.87 KDM4E (0.49) TPH1PDCD1CD274ALDH1A1SLC7A5
Hydrochloric Acid SCHEMBL3751435 0.86 KDM4E (0.48) TPH1PDCD1CD274ALDH1A1SLC7A5
SCHEMBL7960935 0.84 SLC7A5 (0.48) TPH1ALDH1A1SLC7A5PTGS1MMP8
SCHEMBL10679766 0.83 THRB (0.46) TPH1ALDH1A1SLC7A5USP2ADORA3
SCHEMBL2164191 0.83 CYP1A2 (0.42) ALDH1A1KDM4EALOX15HIF1AMMP8
SCHEMBL4881644 0.83 MMP8 (0.44) TPH1SLC7A5PTGS1MMP8PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1587795-B1 N- (1-BENZYL-2-OXO-2- (1-PIPERAZINYL) ETHYL) -1-PIPERIDINCARBOXAMID-DERIVATIVES AND RELATED COMPOUNDS USE AS CGRP-ANTAGONISTS FOR TREATING A HEADACHE BOEHRINGER INGELHEIM INT (DE) 2009-05-13 EP disclosed
US-20040192729-A1 Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192729-A1 Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereof NPY1R, ADCY1, SRD5A1 TPH1 14/4885PDCD1 2398/4885CD274 1682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.